< PreviousTRANSPORT & LOGISTICS30Pharma Business International www.pbiforum.netliving in urban areas… well, the logisticalnightmare is expected to get worse. The other option is to considerexpanding transport fleets toaccommodate for the increaseddemands, with more goods on the roadat any given time to keep product in theretail stores and pharmacies fresh. Whilethis will certainly avoid the issue oflimited warehouse space, the long-termcosts of such an arrangement maybecome untenable for manymanufacturers. Expanding a fleet not onlyincreases fuel and vehicle related costs –but also recruitment costs for drivers,wages and associated HR andadministration costs. There is also theissue of environmental impact andcarbon waste created by a fleet. Becausethe only issue that can match consumer’sdemands for fresher food – is that foodand drink manufacturers should be doingall they can to reduce the impact on theenvironment, not contribute more to it. Many companies are seeking tocombat the issue through a combinedapproach, both of improving theefficiency of their existing transport fleets– while also better utilising existingwarehouse space. Intermodal transport isa popular method utilised predominantlyin the US – but also in Europe as well.The guiding principle is to mix multipleforms of freight transport to achieve a netreduction in costs, be it energy or capital.The typical example would be to use railto shift huge quantities of goods to agiven warehouse closer to the finaldestination – before then having lorriesferry the goods the last distance intourban areas. While this can obviously save manythousands of road miles there is the issueof rail availability, especially in the UK.The reason why it is so prevalent inAmerica is thanks to their abundance offlat land that is suitable for rail. UK railsystems are often not as well developed– and while that hasn’t stoppedcompanies utilising rail for intermodallogistics, it does mean companies aresomewhat limited in location. Beingforced to settle warehouses where the raillinks are strongest. Savings on warehouse space can befound in improving efficiency to increasethe amount of product that can be storedin any given amount of space. Advancedracking solutions, combined with morerobust supply chain systems enablecompanies to increase throughput whilealso cutting costs associated with losttime or product losses. As always, thetrick is in finding out exactly how much ispossible given space limitations – andadapting what can be used for acompany’s products, be they palletisedgoods – or more individually stackedproduce. Even beyond efficient storage howeveris the concept of efficient temperaturecontrol. With the vast majority of pharmaproducts needing to be kept at specifictemperatures there are obviously savingsthat can be made in doing so. After all itis more expensive to reduce thetemperature of a storage facility, than it isto maintain it. Any losses in temperaturedue to breaches, poor worker attention todetail – or just old age, will result in coststhat can soon spiral out of control. Little has changed in terms of thechallenges the industry faces, but as italways has – the technology continues toadapt. Failure to keep in touch with thesechanges and take advantage ofopportunities that present themselvesmay mean disaster for many. 28-31_Layout 1 08/02/2017 16:19 Page 3Pharma Business International 31www.pbiforum.netTRANSPORT & LOGISTICS28-31_Layout 1 08/02/2017 16:19 Page 432Pharma Business International www.pbiforum.netMonday 27 February – Thursday2 March 2017 IFPAC 2017North Bethesda, Maryland IFPAC is dedicated to insightful discussionbringing delegates the latest trends and real-life applications in the pharmaceutical,biotechnology, generic, food and other relatedindustries. The three-day forum will focus onthe latest developments in advancedmanufacturing science, quality initiatives andprocess analytic technologies with anemphasis on emerging technologies, newapplications, software, standards and a look tothe future. High profile speakers will also covercritical and current topics. For moreinformation, visit www.ifpacglobal.org.Monday 6 – Tuesday 7 March3rd Biologics &Biosimilars CongressLeonardo Royal Hotel, Berlin,Germany Industry, academic experts and regulatorybodies will all be in attendance for the 3rdBioligics & Biosimilars Congress, offering aunique opportunity to explore cutting edgestrategies, case studies and regulatoryguidelines to stay on top of this dynamic field.For more information, emailinfo@globalengage.co.uk. Monday 6 – Wednesday 8 MarchePharma 2017Intercontinental New York Times,New York Over 800 pharma, agency, technology andsolution providers leading digital transformationin the pharma and healthcare sectors will cometogether for this on-trend event. The focus willbe on embracing disruptive technology andseizing innovation to grow as a leader and drivethe future of healthcare. For more information,email register@knect365.com. Tuesday 21 – Thursday 23 March Interphex 2017New YorkBased in New York, Interphex brings over10,500 global industry professionals and over600 supplies together to ‘learn it, experience it,procure it’ through a combination of no-costtechnical conferences, exhibits,demonstrations, partnering opportunities andnetworking events to leverage quality, efficiencyand cost effectiveness in today’s constantlyevolving market. For more information, visitwww.interphex.com.Monday 3 – Wednesday 5 AprilISPE EU 2017Crowne Plaza Barcelona – FiraCenter, Barcelona, Spain The focal point for IPSE’s Europe’s annualconference will be Pharma Manufacturing2025, and exploring the means of achieving amodern, agile and flexible productionlandscape. There will be an emphasis ontechnological advancement and regulatorycontrol and the impact both are having on themanufacturer of pharmaceutical and medicalproducts. For example, it will ask what thefacility of the future will look like and howPharmaEVENTSTuesday 21 – Wednesday 22 February201712th Annual BiomarkersCongress 2017Manchester Central ConventionComplex This congress will bring together over 240 delegatesrepresenting leading biotech companies, global pharmaorganisations and internationally renowned academicinstitutions. It will take the form of presentations, casestudies, round-table discussions and panel discussionsfocussed on the key innovations of biomarker researchdiscovery and development. The congress is co-located with the 4th Annual Biomarkers in ClinicalDevelopment Congress. For more information, visitwww.biomarkers-congress.com.32-33_Layout 1 08/02/2017 16:20 Page 1operations will be managed. For moreinformation, email ispe@eurokongress.de. Thursday 20 – Friday 21 April EyeforpharmaPhiladelphia 2017Sheraton Philadelphia SocietyHill HotelThis innovative event will bring together sixin-depth pharma conferences to tackle the keyissues and challenges of 2017 and beyond.The sessions will focus on: commercialleadership, patients as partners, customerexperience, commercial model innovation,pharma’s tripe aim and digital transformation.For more information, visitwww.eyefrpharma.com. Tuesday 25 – Wednesday 26 AprilPrecision MedicineCongress LondonOver two days, this congress will bringtogether 175 senior level attendees fromacademia, research institutes and pharmacompanies to discuss the current challengesand future perspectives of precision medicine.It will provide an ideal platform to participate informal 1-1 meetings and informal networkingdrinks with other key industry figures, as wellas providing opportunities to exchange ideaswith some of the most influential professionalsin this growing field. For more information, visitwww.precisionmedicine-congress.com.Monday 29 – Wednesday 31 MayNanomedicine and DrugDelivery 2017Hyatt Regency, Osaka, JapanThis year, industry experts and employeesalike will converge on Osaka to share theirMonday 27 – Tuesday 28MarchDrug DiscoveryHoliday Inn KensingtonForum, LondonOrganised by SMi, this inauguralconference will bring togetherindustry leaders who will illuminatefuture opportunities for noveltherapeutic discovery. Though recentdevelopments have meant we nowhave a greater understanding of drugdevelopment, there are still a number ofchallenges facing the industry. Thisconference aims to confront and overcomethose challenges. For more information, visitwww.smi-online.co.uk.www.pbiforum.netPharma Business International 33insights and explore the recent developments inthe twin fields of nanomedicine and drugdelivery. As the industry evolves, these twobooming fields will become more prevalent andcommonplace. Stay abreast of the latest trendsand advancements with this event organised byConferenceSeries. For more information, emailnanodelivery@conferenceseries.net. ePharma 201732-33_Layout 1 08/02/2017 16:20 Page 2FEATURESClinical TrialsProcessingHealth and SafetyTraceabilityPackagingWaste ManagementNext issue:Deadline - 29th March 2017REGULARSNewsEventsPharmaBUSINESS INTERNATIONALVisit us atwww.pbiforum.netwhere you’ll find thelatest news as it breaks – and why not subscribe to ournewsletters so you can have thelatest news emailed to yourinbox, in betweenprinted issues?@pbiforumwww.pbiforum.netcompany/po-business-international34_Layout 1 08/02/2017 16:20 Page 1Next >